24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

Gene Therapy Industry, March 2015 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, therapeutics, drug delivery, hospital, biotech, epilepsy, heart failure, hemophilia, regenerative medicine, angina, angina pectoris, arteriosclerosis, atherosclerosis, bladder cancer.


 
1-10 of 54 reports for Gene Therapy

Gene Therapy in Oncology Drug Pipeline Update 2015

Gene Therapy in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

There are today 122 companies plus partners developing 100 gene therapy drugs in 280 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...

Antisense Therapeutics Limited

Antisense Therapeutics Limited

  • $ 55
  • Company report
  • February 2015
  • by Wright Investors' Service

A textual analysis of the financial results for Antisense Therapeutics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Vita 34 International AG (Vita 34) is a pharmaceutical company. The company collects, prepares, processes, and stores stem cells from umbilical cord blood. Its products include vitaplus, vitaplus25, ...

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops ...

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary bluebird bio, Inc. (bluebird bio) is a biotechnology company. The company develops gene therapies for severe genetic and orphan diseases. Its products include LentiGlobin, Lenti D, and CAR T cells. ...

Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 500
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Oncology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene ...

Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Central Nervous System Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain ...

About 600 reports for Gene Therapy

Download Unlimited Documents from Trusted Public Sources

Takara Bio Annual Report 2014

  • January 2014
    38 pages
  • Japan  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.